These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 7667361

  • 1. Conditioned fear exacerbates acute morphine dependence.
    Abrahamsen GC, Caldarone BJ, Stock HS, Schutz AD, Rosellini RA.
    Pharmacol Biochem Behav; 1995; 51(2-3):407-13. PubMed ID: 7667361
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses.
    Amitai N, Liu J, Schulteis G.
    Behav Pharmacol; 2006 May; 17(3):213-22. PubMed ID: 16571999
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine.
    McDonald RV, Parker LA, Siegel S.
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1003-8. PubMed ID: 9408206
    [Abstract] [Full Text] [Related]

  • 6. Conditioned withdrawal in environments associated with the presence or absence of morphine.
    Schnur P, Wainwright M.
    Pharmacol Biochem Behav; 1992 Mar; 41(3):543-6. PubMed ID: 1584832
    [Abstract] [Full Text] [Related]

  • 7. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR, Jones BC, Schulteis G.
    Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
    [Abstract] [Full Text] [Related]

  • 8. Role of withdrawal in reinstatement of morphine-conditioned place preference.
    Lu L, Chen H, Su W, Ge X, Yue W, Su F, Ma L.
    Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats.
    Caillé S, Stinus L, Espejo EF, De Deurwaerdère P, Spampinato U, Koob GF.
    Neuropsychopharmacology; 2003 Feb; 28(2):276-83. PubMed ID: 12589380
    [Abstract] [Full Text] [Related]

  • 18. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
    Kosten TA.
    Eur J Pharmacol; 1994 Mar 11; 254(1-2):59-63. PubMed ID: 8206117
    [Abstract] [Full Text] [Related]

  • 19. The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning.
    Parker LA, Cyr JA, Santi AN, Burton PD.
    Pharmacol Biochem Behav; 2002 May 11; 72(1-2):87-92. PubMed ID: 11900773
    [Abstract] [Full Text] [Related]

  • 20. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs.
    Higgins GA, Sellers EM.
    Pharmacol Biochem Behav; 1994 May 11; 48(1):1-8. PubMed ID: 8029278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.